Cascadia Capital Advises Seattle Reproductive Medicine in Acquisition by Pinnacle Fertility

Seattle Reproductive Medicine Logo has been acquired by Pinnacle Fertility Logo

Cascadia Capital, an investment bank serving middle market clients globally, today announced it acted as the exclusive financial advisor to Seattle Reproductive Medicine (SRM), a leading fertility center headquartered in Seattle, Washington, as they join the Pinnacle Fertility (Pinnacle) network of high-performing family building centers.

For nearly two decades, SRM has helped grow families with comprehensive, expert fertility care. As a center of excellence, SRM brings a special blend of medical expertise, pioneering technology, and a large team including fourteen board-certified physicians, twelve eadvanced registered nurse practitioners, and six practice locations to the Pinnacle network.

“We were honored to work with the team at SRM, a well-recognized regional leader in fertility,” noted Kevin Cable, Cascadia Capital Managing Director. “SRM’s unique platform drove significant interest from potential partners. It was a true testament to the quality of the practice they have built.”

“We are very excited and extremely honored to bring SRM into our organization as they provide an expansive and well-regarded fertility care program to patients as well as the entire Pinnacle network,” states Andrew Mintz, CEO of Pinnacle Fertility, “By expanding our footprint in the Pacific Northwest and welcoming this distinguished team, we are deepening our commitment to leadership, collaboration, and providing the best reproductive care possible to our patients.”

Pinnacle Fertility is the nation’s fastest-growing physician-centered fertility care network, offering fertility-focused practices a platform for collaboration amongst physicians and medical leaders. Pinnacle’s patient-first approach and passion for excellence continues to set the standard in fertility care.

“We considered the opportunity to join the Pinnacle Fertility network thoroughly and felt it was the best path forward for our organization and the patients we support,” adds Dr. Paul Dudley, a leading physician at SRM. “For our patients, the care we provide remains the same high-touch experience we are known for. For our team members, we have a new opportunity to collaborate with medical thought leaders across the nation, access more resources and leading technology, and continue to grow in our field of healthcare. This all directly expands our mission to provide thoughtful, compassionate, and patient-focused fertility care, and that feels good!”

“We are thrilled to leverage the benefits of being a part of a larger network of clinics that celebrates physician leadership, fosters collaboration, offers excellence in medicine and champions success for patients across its programs,” says Dr. Nancy Klein, a founding partner and physician at SRM. “Pinnacle creates more opportunities for patients to access the best reproductive care possible and understands the meaningful work we do every day to help make dreams of building a family possible.”

Cascadia has become a key advisor to clinics and doctors interested in exploring or taking advantage of the increased transaction activity in the reproductive health sector, having advised seven fertility clients in the last twenty four months.

For more information about this transaction, please contact the Cascadia Capital deal team:

Kevin Cable
Managing Director
(206) 696-7922

Vitaliy Marchenko
Senior Vice President
(253) 314-3143

Or other senior members of Cascadia’s Healthcare investment banking team:

Adam Stormoen
Managing Director
(612) 720-8136

Novan Le
Vice President
(206) 436-2510

Back to News